⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23829487 | 1.00 | — | — | |
| SCHEMBL29264685 | 1.00 | — | — | |
| SCHEMBL30543580 | 0.84 | SLC22A6 (0.55) | — | |
| SCHEMBL29148281 | 0.84 | SLC22A6 (0.55) | — | |
| SCHEMBL30543592 | 0.84 | LMNA (0.55) | — | |
| SCHEMBL1268269 | 0.82 | ALDH1A1 (1.00) | — | |
| SCHEMBL28428869 | 0.80 | — | — | |
| Succinic Acid SCHEMBL17975779 | 0.75 | EGLN1 (0.75) | — | |
| Succinic Acid SCHEMBL2148509 | 0.75 | EGLN1 (0.75) | — | |
| Succinic Acid SCHEMBL16415716 | 0.75 | EGLN1 (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021256954-A1 | OXIME-CONTAINING POLYMER | АКЦИОНЕРНОЕ ОБЩЕСТВО "МЕДИКО-БИОЛОГИЧЕСКИЙ НАУЧНО-ПРОИЗВОДСТВЕННЫЙ КОМПЛЕКС ЦИТОМЕД" (АО "МБНПК "ЦИТОМЕД") | 2021-12-23 | — | — | WO | claimed |
| EP-3925967-A1 | OXIME-CONTAINING POLYMER | JSC Cytomed (RU) | 2021-12-22 | — | — | EP | claimed |
| EP-4041795-B1 | BLOCKED ISOCYANATE POLYURETHANE COMPOSITIONS USING A NEW BLOCKING AGENT, METHOD OF MANUFACTURE AND USES THEREOF | CROMOGENIA UNITS (ES) | 2025-10-01 | — | — | EP | disclosed |
| CN-114729101-B | Blocked isocyanate polyurethane composition using blocking agent, method for producing the same, and use thereof | 克罗莫杰尼亚优尼兹公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-111253246-B | Acyl acid derivative and preparation method and medical application thereof | 中国医学科学院基础医学研究所 | 2023-03-17 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-4041795-A1 | BLOCKED ISOCYANATE POLYURETHANE COMPOSITIONS USING A NEW BLOCKING AGENT, METHOD OF MANUFACTURE AND USES THEREOF | Cromogenia Units, S.A. (ES) | 2022-08-17 | — | — | EP | disclosed |
| WO-2021256954-A1 | OXIME-CONTAINING POLYMER | АКЦИОНЕРНОЕ ОБЩЕСТВО "МЕДИКО-БИОЛОГИЧЕСКИЙ НАУЧНО-ПРОИЗВОДСТВЕННЫЙ КОМПЛЕКС ЦИТОМЕД" (АО "МБНПК "ЦИТОМЕД") | 2021-12-23 | — | — | WO | disclosed |
| WO-2021256954-A1 | OXIME-CONTAINING POLYMER | АКЦИОНЕРНОЕ ОБЩЕСТВО "МЕДИКО-БИОЛОГИЧЕСКИЙ НАУЧНО-ПРОИЗВОДСТВЕННЫЙ КОМПЛЕКС ЦИТОМЕД" (АО "МБНПК "ЦИТОМЕД") | 2021-12-23 | — | — | WO | disclosed |
| EP-3925967-A1 | OXIME-CONTAINING POLYMER | JSC Cytomed (RU) | 2021-12-22 | — | — | EP | disclosed |
| EP-3925967-A1 | OXIME-CONTAINING POLYMER | JSC Cytomed (RU) | 2021-12-22 | — | — | EP | disclosed |
| US-6635632-B1 | Alzheimer's disease | ATHENA NEUROSCIENCES, INC. | 2003-10-21 | — | — | US | disclosed |
| US-20030191291-A1 | Synthetic erythropoiesis stimulating proteins | GRYPHON THERAPEUTICS, INC. | 2003-10-09 | — | — | US | disclosed |
| EP-1318827-A1 | POLYMER-MODIFIED SYNTHETIC PROTEINS | Gryphon Therapeutics, Inc. (US) | 2003-06-18 | — | — | EP | disclosed |
| EP-1315513-A2 | \"PSEUDO\"-NATIVE CHEMICAL LIGATION | Gryphon Therapeutics, Inc. (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1315511-A2 | SYNTHETIC ERYTHROPOIESIS STIMULATING PROTEINS | Gryphon Therapeutics, Inc. (US) | 2003-06-04 | — | — | EP | disclosed |
| WO-2002020034-A1 | 'PSEUDO'-NATIVE CHEMICAL LIGATION | GRYPHON THERAPEUTICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002020033-A1 | POLYMER-MODIFIED SYNTHETIC PROTEINS | GRYPHON THERAPEUTICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002019963-A2 | SYNTHETIC ERYTHROPOIESIS STIMULATING PROTEINS | GRYPHON THERAPEUTICS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| US-5514589-A | ACYLATION OF COMPOUND IN THE PRESENCE OF LIPASE IMMOBILIZED ON SUPPORT OF SACCHAROSE | ORION-YHTYMA OY FERMION (FI) | 1996-05-07 | — | — | US | disclosed |